Kula Investments, LLC Catalyst Pharmaceuticals, Inc. Transaction History
Kula Investments, LLC
- $405 Billion
- Q1 2023
A detailed history of Kula Investments, LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Kula Investments, LLC holds 20,488 shares of CPRX stock, worth $358,130. This represents 0.08% of its overall portfolio holdings.
Number of Shares
20,488Holding current value
$358,130% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding CPRX
# of Institutions
279Shares Held
95.6MCall Options Held
40.6KPut Options Held
67.2K-
Black Rock Inc. New York, NY17.7MShares$310 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY9.13MShares$160 Million3.01% of portfolio
-
State Street Corp Boston, MA8.15MShares$143 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.98MShares$140 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.74MShares$47.9 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $1.8B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...